Kelly Niethammer joined Blue Matter in 2024, bringing over a year of life sciences consulting and biomedical product experience to the team. Her project work spans launch strategy and planning, situation and customer engagement analysis, and commercial and brand strategy, with a focus on oncology, rare disease, and vaccines.

Kelly holds a B.S. in Human Biology from Stanford University.